0 XP   0   0   0

ANG Lifesciences India Ltd
Buy, Hold or Sell?

Should you buy, hold or sell ANG Lifesciences India Ltd?

I guess you are interested in ANG Lifesciences India Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse ANG Lifesciences India Ltd

Let's start. I'm going to help you getting a better view of ANG Lifesciences India Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is ANG Lifesciences India Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how ANG Lifesciences India Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value ANG Lifesciences India Ltd. The closing price on 2023-02-08 was INR101.00 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
ANG Lifesciences India Ltd Daily Candlestick Chart
ANG Lifesciences India Ltd Daily Candlestick Chart
Summary









1. Valuation of ANG Lifesciences India Ltd




Current price per share

INR101.00

2. Growth of ANG Lifesciences India Ltd




Is ANG Lifesciences India Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$10.1m$5m$5.1m50.4%

How much money is ANG Lifesciences India Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4.8m$850.3k$4m82.6%
Net Profit Margin11.4%4.6%--

How much money comes from the company's main activities?

3. Financial Health of ANG Lifesciences India Ltd




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

1.1. Profitability of ANG Lifesciences India Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ANG Lifesciences India Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • A Net Profit Margin of 11.4% means that ₹0.11 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ANG Lifesciences India Ltd:

  • The MRQ is 11.4%. The company is making a huge profit. +2
  • The TTM is 11.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.4%TTM11.4%0.0%
TTM11.4%YOY4.6%+6.8%
TTM11.4%5Y6.3%+5.0%
5Y6.3%10Y6.3%0.0%
1.1.2. Return on Assets

Shows how efficient ANG Lifesciences India Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • 13.9% Return on Assets means that ANG Lifesciences India Ltd generated ₹0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ANG Lifesciences India Ltd:

  • The MRQ is 13.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 13.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ13.9%TTM13.9%0.0%
TTM13.9%YOY4.9%+9.0%
TTM13.9%5Y8.1%+5.8%
5Y8.1%10Y8.1%0.0%
1.1.3. Return on Equity

Shows how efficient ANG Lifesciences India Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • 48.1% Return on Equity means ANG Lifesciences India Ltd generated ₹0.48 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ANG Lifesciences India Ltd:

  • The MRQ is 48.1%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 48.1%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ48.1%TTM48.1%0.0%
TTM48.1%YOY16.9%+31.2%
TTM48.1%5Y25.6%+22.6%
5Y25.6%10Y25.6%0.0%

1.2. Operating Efficiency of ANG Lifesciences India Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ANG Lifesciences India Ltd is operating .

  • Measures how much profit ANG Lifesciences India Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ANG Lifesciences India Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y4.3%-4.3%
5Y4.3%10Y4.3%0.0%
1.2.2. Operating Ratio

Measures how efficient ANG Lifesciences India Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.46 means that the operating costs are ₹1.46 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 1.464. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.464. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.464TTM1.4640.000
TTM1.464YOY1.582-0.118
TTM1.4645Y1.569-0.105
5Y1.56910Y1.5690.000

1.3. Liquidity of ANG Lifesciences India Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ANG Lifesciences India Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.16 means the company has ₹1.16 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 1.159. The company is just able to pay all its short-term debts.
  • The TTM is 1.159. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.159TTM1.1590.000
TTM1.159YOY1.265-0.106
TTM1.1595Y1.317-0.157
5Y1.31710Y1.3170.000
1.3.2. Quick Ratio

Measures if ANG Lifesciences India Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • A Quick Ratio of 0.65 means the company can pay off ₹0.65 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 0.652. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.652. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.652TTM0.6520.000
TTM0.652YOY0.642+0.010
TTM0.6525Y0.846-0.194
5Y0.84610Y0.8460.000

1.4. Solvency of ANG Lifesciences India Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ANG Lifesciences India Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ANG Lifesciences India Ltd to industry mean.
  • A Debt to Asset Ratio of 0.71 means that ANG Lifesciences India Ltd assets are financed with 71.2% credit (debt) and the remaining percentage (100% - 71.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 0.712. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.712. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.712TTM0.7120.000
TTM0.712YOY0.711+0.002
TTM0.7125Y0.675+0.037
5Y0.67510Y0.6750.000
1.4.2. Debt to Equity Ratio

Measures if ANG Lifesciences India Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • A Debt to Equity ratio of 247.4% means that company has ₹2.47 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 2.474. The company is just not able to pay all its debts with equity.
  • The TTM is 2.474. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.474TTM2.4740.000
TTM2.474YOY2.455+0.020
TTM2.4745Y2.115+0.359
5Y2.11510Y2.1150.000

2. Market Valuation of ANG Lifesciences India Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings ANG Lifesciences India Ltd generates.

  • Above 15 is considered overpriced but always compare ANG Lifesciences India Ltd to the  industry mean.
  • A PE ratio of 7.54 means the investor is paying ₹7.54 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ANG Lifesciences India Ltd:

  • The EOD is 3.246. Very good. +2
  • The MRQ is 7.540. Very good. +2
  • The TTM is 7.540. Very good. +2
Trends
Current periodCompared to+/- 
EOD3.246MRQ7.540-4.294
MRQ7.540TTM7.5400.000
TTM7.540YOY15.821-8.280
TTM7.5405Y10.200-2.660
5Y10.20010Y10.2000.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of ANG Lifesciences India Ltd.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 1.314. Seems overpriced? -1
  • The TTM is 1.314. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ1.314TTM1.3140.000
TTM1.314YOY13.723-12.408
TTM1.3145Y6.994-5.680
5Y6.99410Y6.9940.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ANG Lifesciences India Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 3.63 means the investor is paying ₹3.63 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ANG Lifesciences India Ltd:

  • The EOD is 1.562. Good. +1
  • The MRQ is 3.629. Neutral. Compare to industry.
  • The TTM is 3.629. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD1.562MRQ3.629-2.067
MRQ3.629TTM3.6290.000
TTM3.629YOY2.674+0.955
TTM3.6295Y2.399+1.230
5Y2.39910Y2.3990.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ANG Lifesciences India Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--32.55532.5550%5.385+505%16.161+101%16.161+101%
Book Value Growth--2.0142.0140%1.202+68%1.473+37%1.473+37%
Book Value Per Share--64.64564.6450%32.090+101%36.410+78%36.410+78%
Book Value Per Share Growth--2.0142.0140%1.202+68%1.473+37%1.473+37%
Current Ratio--1.1591.1590%1.265-8%1.317-12%1.317-12%
Debt To Asset Ratio--0.7120.7120%0.711+0%0.675+6%0.675+6%
Debt To Equity Ratio--2.4742.4740%2.455+1%2.115+17%2.115+17%
Dividend Per Share--0.7990.7990%-+100%0.200+300%0.200+300%
Eps--31.11331.1130%5.423+474%11.399+173%11.399+173%
Eps Growth--5.7375.7370%1.153+398%2.657+116%2.657+116%
Free Cash Flow Per Share---12.832-12.8320%3.781-439%-0.370-97%-0.370-97%
Free Cash Flow Per Share Growth---3.394-3.3940%1.537-321%-0.458-86%-0.458-86%
Free Cash Flow To Equity Per Share---12.832-12.8320%3.781-439%-1.864-85%-1.864-85%
Free Cash Flow To Equity Per Share Growth---3.394-3.3940%8.477-140%1.605-311%1.605-311%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.1140.1140%0.046+150%0.063+79%0.063+79%
Operating Margin----0%-0%0.043-100%0.043-100%
Operating Ratio--1.4641.4640%1.582-7%1.569-7%1.569-7%
Pb Ratio1.562-132%3.6293.6290%2.674+36%2.399+51%2.399+51%
Pe Ratio3.246-132%7.5407.5400%15.821-52%10.200-26%10.200-26%
Peg Ratio--1.3141.3140%13.723-90%6.994-81%6.994-81%
Price Per Share101.000-132%234.600234.6000%85.800+173%99.650+135%99.650+135%
Price To Total Gains Ratio3.028-132%7.0347.0340%15.934-56%7.958-12%7.958-12%
Profit Growth--5.7375.7370%1.153+398%2.656+116%2.656+116%
Quick Ratio--0.6520.6520%0.642+2%0.846-23%0.846-23%
Return On Assets--0.1390.1390%0.049+183%0.081+72%0.081+72%
Return On Equity--0.4810.4810%0.169+185%0.256+88%0.256+88%
Revenue Growth--2.2952.2950%1.217+89%1.518+51%1.518+51%
Total Gains Per Share--33.35433.3540%5.385+519%16.361+104%16.361+104%
Total Gains Per Share Growth--6.1946.1940%1.195+418%2.531+145%2.531+145%
Usd Book Value--10136061.10010136061.1000%5031554.568+101%5708930.158+78%5708930.158+78%
Usd Book Value Change Per Share--0.3940.3940%0.065+505%0.196+101%0.196+101%
Usd Book Value Per Share--0.7820.7820%0.388+101%0.441+78%0.441+78%
Usd Dividend Per Share--0.0100.0100%-+100%0.002+300%0.002+300%
Usd Eps--0.3760.3760%0.066+474%0.138+173%0.138+173%
Usd Free Cash Flow---2011939.600-2011939.6000%592851.043-439%-58051.030-97%-58051.030-97%
Usd Free Cash Flow Per Share---0.155-0.1550%0.046-439%-0.004-97%-0.004-97%
Usd Free Cash Flow To Equity Per Share---0.155-0.1550%0.046-439%-0.023-85%-0.023-85%
Usd Price Per Share1.222-132%2.8392.8390%1.038+173%1.206+135%1.206+135%
Usd Profit--4878296.5004878296.5000%850343.291+474%1787434.058+173%1787434.058+173%
Usd Revenue--42870505.70042870505.7000%18679853.712+130%22905651.547+87%22905651.547+87%
Usd Total Gains Per Share--0.4040.4040%0.065+519%0.198+104%0.198+104%
 EOD+3 -2MRQTTM+0 -0YOY+27 -135Y+26 -1510Y+26 -15

3.2. Fundamental Score

Let's check the fundamental score of ANG Lifesciences India Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-153.246
Price to Book Ratio (EOD)Between0-11.562
Net Profit Margin (MRQ)Greater than00.114
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.652
Current Ratio (MRQ)Greater than11.159
Debt to Asset Ratio (MRQ)Less than10.712
Debt to Equity Ratio (MRQ)Less than12.474
Return on Equity (MRQ)Greater than0.150.481
Return on Assets (MRQ)Greater than0.050.139
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of ANG Lifesciences India Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose101.700
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets2,910,304
Total Liabilities2,072,613
Total Stockholder Equity837,691
 As reported
Total Liabilities 2,072,613
Total Stockholder Equity+ 837,691
Total Assets = 2,910,304

Assets

Total Assets2,910,304
Total Current Assets1,928,121
Long-term Assets1,928,121
Total Current Assets
Cash And Cash Equivalents 3,460
Short-term Investments 63,062
Net Receivables 1,020,550
Inventory 369,591
Other Current Assets 110
Total Current Assets  (as reported)1,928,121
Total Current Assets  (calculated)1,456,773
+/- 471,348
Long-term Assets
Long-term Assets  (as reported)982,183
Long-term Assets  (calculated)0
+/- 982,183

Liabilities & Shareholders' Equity

Total Current Liabilities1,662,893
Long-term Liabilities409,720
Total Stockholder Equity837,691
Total Current Liabilities
Short Long Term Debt 553,581
Accounts payable 706,290
Other Current Liabilities 75,002
Total Current Liabilities  (as reported)1,662,893
Total Current Liabilities  (calculated)1,334,873
+/- 328,020
Long-term Liabilities
Long term Debt 216,370
Long-term Liabilities  (as reported)409,720
Long-term Liabilities  (calculated)216,370
+/- 193,350
Total Stockholder Equity
Retained Earnings 621,022
Total Stockholder Equity (as reported)837,691
Total Stockholder Equity (calculated)621,022
+/- 216,669
Other
Capital Stock103,666
Common Stock Shares Outstanding 12,958
Net Debt 766,491
Net Invested Capital 1,607,642
Net Working Capital 265,228



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
808,976
940,751
1,436,509
2,910,304
2,910,3041,436,509940,751808,97600
   > Total Current Assets 
377,572
468,746
599,590
727,129
1,158,691
1,928,121
1,928,1211,158,691727,129599,590468,746377,572
       Cash And Cash Equivalents 
0
0
43,715
36,005
1,437
3,460
3,4601,43736,00543,71500
       Short-term Investments 
0
0
0
0
0
63,062
63,06200000
       Net Receivables 
257,216
354,620
442,218
533,156
587,433
1,020,550
1,020,550587,433533,156442,218354,620257,216
       Inventory 
58,408
77,429
65,373
100,043
192,587
369,591
369,591192,587100,04365,37377,42958,408
       Other Current Assets 
52,708
21,622
48,000
57,925
107,873
110
110107,87357,92548,00021,62252,708
   > Long-term Assets 
0
0
209,386
422,996
277,818
982,183
982,183277,818422,996209,38600
       Property Plant Equipment 
89,730
208,784
205,965
209,373
0
0
00209,373205,965208,78489,730
       Intangible Assets 
0
0
0
2,312
2,312
0
02,3122,312000
       Long-term Assets Other 
0
0
1,592
1,737
1,245
-2
-21,2451,7371,59200
> Total Liabilities 
0
0
521,303
594,697
1,020,678
2,072,613
2,072,6131,020,678594,697521,30300
   > Total Current Liabilities 
342,107
354,460
424,044
508,969
915,613
1,662,893
1,662,893915,613508,969424,044354,460342,107
       Short Long Term Debt 
0
0
156,240
155,645
361,320
553,581
553,581361,320155,645156,24000
       Accounts payable 
213,918
223,152
218,146
257,896
400,402
706,290
706,290400,402257,896218,146223,152213,918
       Other Current Liabilities 
19,849
15,500
28,425
121,879
135,353
75,002
75,002135,353121,87928,42515,50019,849
   > Long-term Liabilities 
0
0
97,260
86,227
105,066
409,720
409,720105,06686,22797,26000
       Long-term Liabilities Other 
0
0
4,008
3,621
2,857
0
02,8573,6214,00800
> Total Stockholder Equity
0
0
287,673
346,055
415,831
837,691
837,691415,831346,055287,67300
   Retained Earnings 
36,566
73,794
130,284
188,666
258,942
621,022
621,022258,942188,666130,28473,79436,566
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue3,543,017
Cost of Revenue-2,279,821
Gross Profit1,263,1961,263,196
 
Operating Income (+$)
Gross Profit1,263,196
Operating Expense-2,906,770
Operating Income636,247-1,643,574
 
Operating Expense (+$)
Research Development-
Selling General Administrative83,903
Selling And Marketing Expenses-
Operating Expense2,906,77083,903
 
Net Interest Income (+$)
Interest Income2,874
Interest Expense-82,795
Net Interest Income-91,344-79,921
 
Pretax Income (+$)
Operating Income636,247
Net Interest Income-91,344
Other Non-Operating Income Expenses-
Income Before Tax (EBT)535,005636,247
EBIT - interestExpense = -82,795
403,165
485,960
Interest Expense82,795
Earnings Before Interest and Taxes (ebit)-617,800
Earnings Before Interest and Taxes (ebitda)676,552
 
After tax Income (+$)
Income Before Tax535,005
Tax Provision-131,840
Net Income From Continuing Ops403,165403,165
Net Income403,165
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-91,344
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
WAAREE.BSE
now

I found you a Morning Star Candle Pattern on the daily chart of WAAREE.BSE.

WAAREE.BSE Daily Candlestick Chart
UNICHEMLAB.BSE
6 minutes ago

I found you a Death Cross on the daily chart of UNICHEMLAB.BSE.

UNICHEMLAB.BSE Daily Candlestick Chart
TRIVENIENT.BSE
8 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIVENIENT.BSE.

TRIVENIENT.BSE Daily Candlestick Chart
TINNARUBR.BSE
11 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of TINNARUBR.BSE.

TINNARUBR.BSE Daily Candlestick Chart
WAT.AU
13 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WAT.AU.

WAT.AU Daily Candlestick Chart
SYMBIOX.BSE
14 minutes ago

I found you a Death Cross on the daily chart of SYMBIOX.BSE.

SYMBIOX.BSE Daily Candlestick Chart
SUPERBAK.BSE
15 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of SUPERBAK.BSE.

SUPERBAK.BSE Daily Candlestick Chart
ABVL.BSE
16 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ABVL.BSE.

ABVL.BSE Daily Candlestick Chart
RAVALSUGAR.BSE
16 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RAVALSUGAR.BSE.

RAVALSUGAR.BSE Daily Candlestick Chart
PAYTM*.BSE
17 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PAYTM*.BSE.

PAYTM*.BSE Daily Candlestick Chart
GARGI.BSE
17 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of GARGI.BSE.

GARGI.BSE Daily Candlestick Chart
VRFILMS.BSE
18 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VRFILMS.BSE.

VRFILMS.BSE Daily Candlestick Chart
IFINSER.BSE
18 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of IFINSER.BSE.

IFINSER.BSE Daily Candlestick Chart
MILESTONE.BSE
18 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of MILESTONE.BSE.

MILESTONE.BSE Daily Candlestick Chart
SRDAPRT.BSE
19 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of SRDAPRT.BSE.

SRDAPRT.BSE Daily Candlestick Chart
SONATSOFTW.BSE
19 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of SONATSOFTW.BSE.

SONATSOFTW.BSE Daily Candlestick Chart
SHREEGANES.BSE
21 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHREEGANES.BSE.

SHREEGANES.BSE Daily Candlestick Chart
SCOOBEEDAY.BSE
22 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SCOOBEEDAY.BSE.

SCOOBEEDAY.BSE Daily Candlestick Chart
SCHAEFFLER.BSE
22 minutes ago

I found you a Death Cross on the daily chart of SCHAEFFLER.BSE.

SCHAEFFLER.BSE Daily Candlestick Chart
SARTHAKIND.BSE
22 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of SARTHAKIND.BSE.

SARTHAKIND.BSE Daily Candlestick Chart
SARLAPOLY.BSE
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SARLAPOLY.BSE.

SARLAPOLY.BSE Daily Candlestick Chart
SADHNA.BSE
23 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of SADHNA.BSE.

SADHNA.BSE Daily Candlestick Chart
SADBHIN.BSE
24 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SADBHIN.BSE.

SADBHIN.BSE Daily Candlestick Chart
RUCHIRA.BSE
24 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RUCHIRA.BSE.

RUCHIRA.BSE Daily Candlestick Chart